Patients who have used Littfulo, Torcap, Fruzakura, Omjara, Michiga, or Kelendia.
Conditions
Interventions
Use of an early adverse drug reaction detection system
Sponsors
Kondo Tomoko
Eligibility
Inclusion criteria
Inclusion criteria: [Patients] 1. Individuals who bring a prescription containing one of the target drugs, "Litfulo," "Torcap," "Fruzakura," "Omjara," "Michiga," or "Kelendia," to a Sugi Pharmacy or Minaminihon Pharmaceutical Center pharmacy. 2. Individuals aged 16 years or older at the time of consent (regardless of gender). 3. Individuals who have received a full explanation of this study and, after fully understanding it, have given their voluntary written consent. [Pharmacists] 1. All pharmacists working at a Sugi Pharmacy or Minaminihon Pharmaceutical Center pharmacy. 2. Pharmacists who dispense prescriptions to patients who bring a prescription containing one of the target drugs, "Litfulo," "Torcap," "Fruzakura," "Omjara," "Michiga," or "Kelendia."
Exclusion criteria
Exclusion criteria: [Patients] 1. Those with a history of severe mental illness 2. Those who are mentally and physically unstable and whose physical condition may be adversely affected by participating in this study 3. Those who do not own a smartphone or other communication device and cannot have one provided by the pharmacy 4. Those deemed inappropriate by the pharmacy pharmacist [Pharmacists] *No exclusion criteria will be set.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of adverse drug reactions obtained by this system | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of adverse drug reactions reported to attending physicians, number of unknown adverse drug reactions detected (including trends by age and gender), and satisfaction of insurance pharmacy pharmacists when using this system | — |
Contacts
Public ContactTomoko Kondo
Kagoshima University
Outcome results
None listed